Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population

Gustavo A. Rubio, Andrea Alvarado, David J. Gerth, Jun Tashiro, Seth Thaller

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background: Dermatofibrosarcoma protuberans (DFSP) is a lowgrade soft tissue sarcoma. In the pediatric population, DFSP is exceedingly rare. Aim of this study was to describe the epidemiology and clinical outcomes in a large pediatric cohort. Methods: Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) was analyzed for all patients with dermatofibrosarcoma occurring in patients <20 years of age. Data were extracted based on age, gender, race, anatomic site, histology, stage, treatment modalities, and survival. Incidence rates were standardized to the 2000 US population. Results: A total of 451 patients were identified. Overall annual incidence was 0.10 per 100,000. Incidence was highest among black children and adolescents (ages 15 to 19 years). Trunk was most common site, followed by extremities. Head and neck region was least common site (P<0.05). Majority (54%) of patients presented with localized disease. Overall, 95% underwent surgery. Only 2.2% were treated with perioperative radiation therapy. Overall prognosis was favorable with 5-year overall survival (OS) of 100%, 15-year OS of 98%, and 30-year OS of 97%. Median survival was 117 months. Male patients had lower 15- and 30-year OS compared with females (P<0.05). Conclusion: Pediatric DFSP has lower incidence but similar clinical characteristics to adults. Incidence is higher in black children and in the trunk region. While prognosis is favorable, male sex is associated with decreased OS.

Original languageEnglish (US)
Pages (from-to)182-184
Number of pages3
JournalJournal of Craniofacial Surgery
Volume28
Issue number1
DOIs
StatePublished - 2017

Fingerprint

Dermatofibrosarcoma
Pediatrics
Survival
Incidence
Population
Epidemiology
Sarcoma
Histology
Neck
Radiotherapy
Extremities
Head
Databases

Keywords

  • Dermatofibrosarcoma protuberans
  • Pediatric
  • Sarcoma
  • SEER
  • Soft tissue tumor

ASJC Scopus subject areas

  • Surgery
  • Otorhinolaryngology

Cite this

Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population. / Rubio, Gustavo A.; Alvarado, Andrea; Gerth, David J.; Tashiro, Jun; Thaller, Seth.

In: Journal of Craniofacial Surgery, Vol. 28, No. 1, 2017, p. 182-184.

Research output: Contribution to journalArticle

Rubio, Gustavo A. ; Alvarado, Andrea ; Gerth, David J. ; Tashiro, Jun ; Thaller, Seth. / Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population. In: Journal of Craniofacial Surgery. 2017 ; Vol. 28, No. 1. pp. 182-184.
@article{5d5b5236b852496998fd92e1fff01501,
title = "Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population",
abstract = "Background: Dermatofibrosarcoma protuberans (DFSP) is a lowgrade soft tissue sarcoma. In the pediatric population, DFSP is exceedingly rare. Aim of this study was to describe the epidemiology and clinical outcomes in a large pediatric cohort. Methods: Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) was analyzed for all patients with dermatofibrosarcoma occurring in patients <20 years of age. Data were extracted based on age, gender, race, anatomic site, histology, stage, treatment modalities, and survival. Incidence rates were standardized to the 2000 US population. Results: A total of 451 patients were identified. Overall annual incidence was 0.10 per 100,000. Incidence was highest among black children and adolescents (ages 15 to 19 years). Trunk was most common site, followed by extremities. Head and neck region was least common site (P<0.05). Majority (54{\%}) of patients presented with localized disease. Overall, 95{\%} underwent surgery. Only 2.2{\%} were treated with perioperative radiation therapy. Overall prognosis was favorable with 5-year overall survival (OS) of 100{\%}, 15-year OS of 98{\%}, and 30-year OS of 97{\%}. Median survival was 117 months. Male patients had lower 15- and 30-year OS compared with females (P<0.05). Conclusion: Pediatric DFSP has lower incidence but similar clinical characteristics to adults. Incidence is higher in black children and in the trunk region. While prognosis is favorable, male sex is associated with decreased OS.",
keywords = "Dermatofibrosarcoma protuberans, Pediatric, Sarcoma, SEER, Soft tissue tumor",
author = "Rubio, {Gustavo A.} and Andrea Alvarado and Gerth, {David J.} and Jun Tashiro and Seth Thaller",
year = "2017",
doi = "10.1097/SCS.0000000000003203",
language = "English (US)",
volume = "28",
pages = "182--184",
journal = "Journal of Craniofacial Surgery",
issn = "1049-2275",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Incidence and outcomes of dermatofibrosarcoma protuberans in the US pediatric population

AU - Rubio, Gustavo A.

AU - Alvarado, Andrea

AU - Gerth, David J.

AU - Tashiro, Jun

AU - Thaller, Seth

PY - 2017

Y1 - 2017

N2 - Background: Dermatofibrosarcoma protuberans (DFSP) is a lowgrade soft tissue sarcoma. In the pediatric population, DFSP is exceedingly rare. Aim of this study was to describe the epidemiology and clinical outcomes in a large pediatric cohort. Methods: Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) was analyzed for all patients with dermatofibrosarcoma occurring in patients <20 years of age. Data were extracted based on age, gender, race, anatomic site, histology, stage, treatment modalities, and survival. Incidence rates were standardized to the 2000 US population. Results: A total of 451 patients were identified. Overall annual incidence was 0.10 per 100,000. Incidence was highest among black children and adolescents (ages 15 to 19 years). Trunk was most common site, followed by extremities. Head and neck region was least common site (P<0.05). Majority (54%) of patients presented with localized disease. Overall, 95% underwent surgery. Only 2.2% were treated with perioperative radiation therapy. Overall prognosis was favorable with 5-year overall survival (OS) of 100%, 15-year OS of 98%, and 30-year OS of 97%. Median survival was 117 months. Male patients had lower 15- and 30-year OS compared with females (P<0.05). Conclusion: Pediatric DFSP has lower incidence but similar clinical characteristics to adults. Incidence is higher in black children and in the trunk region. While prognosis is favorable, male sex is associated with decreased OS.

AB - Background: Dermatofibrosarcoma protuberans (DFSP) is a lowgrade soft tissue sarcoma. In the pediatric population, DFSP is exceedingly rare. Aim of this study was to describe the epidemiology and clinical outcomes in a large pediatric cohort. Methods: Surveillance, Epidemiology, and End Results (SEER) database (1973-2010) was analyzed for all patients with dermatofibrosarcoma occurring in patients <20 years of age. Data were extracted based on age, gender, race, anatomic site, histology, stage, treatment modalities, and survival. Incidence rates were standardized to the 2000 US population. Results: A total of 451 patients were identified. Overall annual incidence was 0.10 per 100,000. Incidence was highest among black children and adolescents (ages 15 to 19 years). Trunk was most common site, followed by extremities. Head and neck region was least common site (P<0.05). Majority (54%) of patients presented with localized disease. Overall, 95% underwent surgery. Only 2.2% were treated with perioperative radiation therapy. Overall prognosis was favorable with 5-year overall survival (OS) of 100%, 15-year OS of 98%, and 30-year OS of 97%. Median survival was 117 months. Male patients had lower 15- and 30-year OS compared with females (P<0.05). Conclusion: Pediatric DFSP has lower incidence but similar clinical characteristics to adults. Incidence is higher in black children and in the trunk region. While prognosis is favorable, male sex is associated with decreased OS.

KW - Dermatofibrosarcoma protuberans

KW - Pediatric

KW - Sarcoma

KW - SEER

KW - Soft tissue tumor

UR - http://www.scopus.com/inward/record.url?scp=85002002616&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85002002616&partnerID=8YFLogxK

U2 - 10.1097/SCS.0000000000003203

DO - 10.1097/SCS.0000000000003203

M3 - Article

C2 - 27922973

AN - SCOPUS:85002002616

VL - 28

SP - 182

EP - 184

JO - Journal of Craniofacial Surgery

JF - Journal of Craniofacial Surgery

SN - 1049-2275

IS - 1

ER -